Nephrogen
June 24, 2026
5B
Type: Start-Up Stadium Session
Focus Area:
Platform for Therapeutics
Nephrogen is a biotech spin-out from Stanford University developing curative genomic medicines for kidney and pancreatic diseases.
Company HQ City:
New York
Company HQ State:
NY
Company HQ Country:
United States
Year Founded:
2022
CEO
Demetri Maxim
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}